GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (WBO:GRF) » Definitions » Short-term investments

Grifols (WBO:GRF) Short-term investments


View and export this data going back to 2017. Start your Free Trial

What is Grifols Short-term investments?

Short-term investments only applies to insurance companies.


Grifols Business Description

Address
Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.